Series B funding round for Purespring Therapeutics raising $110M in October 2024
Series B funding round for Purespring Therapeutics raising $110M in October 2024
| Investor | Firm Type | Partner |
|---|---|---|
| Venture Capital |
| — |
| Angel | Therese Liechtenstein |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$170M
Top Valuation
-
Purespring Therapeutics raised $110M in a Series B round.
The round was announced on 10/01/24.